Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HNR4
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006259 | DNA metabolic process | 4 | 3 |
GO:0006281 | DNA repair | 5 | 3 |
GO:0006289 | nucleotide-excision repair | 6 | 3 |
GO:0006508 | proteolysis | 4 | 4 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 4 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 4 |
GO:0006950 | response to stress | 2 | 3 |
GO:0006974 | DNA damage response | 4 | 3 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0009056 | catabolic process | 2 | 4 |
GO:0009057 | macromolecule catabolic process | 4 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0010498 | proteasomal protein catabolic process | 5 | 3 |
GO:0019538 | protein metabolic process | 3 | 4 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 4 |
GO:0030163 | protein catabolic process | 4 | 3 |
GO:0033554 | cellular response to stress | 3 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 4 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0044248 | cellular catabolic process | 3 | 4 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 4 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 4 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0050896 | response to stimulus | 1 | 3 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 4 |
GO:0051716 | cellular response to stimulus | 2 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 4 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 3 |
GO:1901575 | organic substance catabolic process | 3 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003677 | DNA binding | 4 | 3 |
GO:0003684 | damaged DNA binding | 5 | 3 |
GO:0005488 | binding | 1 | 4 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
GO:0005515 | protein binding | 2 | 1 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 4 | 1 |
GO:0140030 | modification-dependent protein binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.211 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.278 |
CLV_Separin_Metazoa | 219 | 223 | PF03568 | 0.587 |
DEG_APCC_DBOX_1 | 278 | 286 | PF00400 | 0.420 |
DEG_SCF_FBW7_1 | 85 | 92 | PF00400 | 0.492 |
DOC_PP2B_LxvP_1 | 35 | 38 | PF13499 | 0.533 |
DOC_PP4_FxxP_1 | 127 | 130 | PF00568 | 0.716 |
DOC_PP4_FxxP_1 | 265 | 268 | PF00568 | 0.542 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.588 |
DOC_USP7_MATH_1 | 232 | 236 | PF00917 | 0.545 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.597 |
DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.601 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.578 |
DOC_WW_Pin1_4 | 250 | 255 | PF00397 | 0.685 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.666 |
DOC_WW_Pin1_4 | 99 | 104 | PF00397 | 0.669 |
LIG_14-3-3_CanoR_1 | 72 | 78 | PF00244 | 0.641 |
LIG_BRCT_BRCA1_1 | 261 | 265 | PF00533 | 0.591 |
LIG_EH_1 | 146 | 150 | PF12763 | 0.633 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.436 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.299 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.573 |
LIG_FHA_1 | 251 | 257 | PF00498 | 0.681 |
LIG_FHA_1 | 32 | 38 | PF00498 | 0.474 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.516 |
LIG_IBAR_NPY_1 | 118 | 120 | PF08397 | 0.527 |
LIG_IBAR_NPY_1 | 223 | 225 | PF08397 | 0.621 |
LIG_LIR_Apic_2 | 125 | 130 | PF02991 | 0.711 |
LIG_LIR_Apic_2 | 262 | 268 | PF02991 | 0.580 |
LIG_NRBOX | 310 | 316 | PF00104 | 0.420 |
LIG_PCNA_yPIPBox_3 | 214 | 222 | PF02747 | 0.515 |
LIG_PCNA_yPIPBox_3 | 271 | 279 | PF02747 | 0.349 |
LIG_PDZ_Class_2 | 312 | 317 | PF00595 | 0.480 |
LIG_PTB_Apo_2 | 189 | 196 | PF02174 | 0.527 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.523 |
LIG_SH2_STAP1 | 120 | 124 | PF00017 | 0.542 |
LIG_SH2_STAT3 | 198 | 201 | PF00017 | 0.578 |
LIG_SH2_STAT3 | 225 | 228 | PF00017 | 0.596 |
LIG_SH2_STAT3 | 278 | 281 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.553 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.680 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.610 |
LIG_SUMO_SIM_par_1 | 13 | 19 | PF11976 | 0.472 |
LIG_TRAF2_1 | 291 | 294 | PF00917 | 0.356 |
LIG_TRAF2_1 | 38 | 41 | PF00917 | 0.425 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.671 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.635 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.533 |
MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.481 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.587 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.265 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.458 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.617 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.565 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.590 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.591 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.569 |
MOD_N-GLC_1 | 20 | 25 | PF02516 | 0.271 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.742 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.315 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.447 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.578 |
MOD_PIKK_1 | 105 | 111 | PF00454 | 0.490 |
MOD_PIKK_1 | 129 | 135 | PF00454 | 0.698 |
MOD_PIKK_1 | 97 | 103 | PF00454 | 0.546 |
MOD_Plk_1 | 20 | 26 | PF00069 | 0.485 |
MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.598 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.574 |
MOD_ProDKin_1 | 250 | 256 | PF00069 | 0.684 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.669 |
MOD_ProDKin_1 | 99 | 105 | PF00069 | 0.673 |
MOD_SUMO_for_1 | 51 | 54 | PF00179 | 0.371 |
TRG_DiLeu_BaEn_1 | 280 | 285 | PF01217 | 0.446 |
TRG_DiLeu_BaEn_3 | 40 | 46 | PF01217 | 0.468 |
TRG_DiLeu_BaLyEn_6 | 310 | 315 | PF01217 | 0.299 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.510 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I781 | Leptomonas seymouri | 61% | 100% |
A0A0S4JQ29 | Bodo saltans | 43% | 100% |
A0A1X0P8J6 | Trypanosomatidae | 37% | 100% |
A0A3S7XAB2 | Leishmania donovani | 80% | 100% |
A0A422P276 | Trypanosoma rangeli | 39% | 100% |
A4ICT1 | Leishmania infantum | 80% | 100% |
D0A2M4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9ASH3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
P48510 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 85% |
Q4Q222 | Leishmania major | 80% | 100% |
V5BZY0 | Trypanosoma cruzi | 40% | 88% |